Overview

Multiple Doses of DM199 in Patients With Chronic Kidney Disease

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
An open-label, Phase II, multi-center study evaluating multiple doses of DM199 in participants with chronic kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
DiaMedica Therapeutics Inc